ProCE Banner Activity

ExpressPoints:
Navigating the Complex Treatment Landscape in Relapsed/Refractory Myeloma

Slideset Download
Download this short summary slideset of key takeaways from a live webinar on best practices with treatment selection for patients with relapsed/refractory multiple myeloma.

Released: September 22, 2022

Expiration: September 21, 2023

Share

Provided by

Provided by Medical Learning Institute, Inc. in partnership with Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by educational grants from

Janssen administered by Scientific Affairs

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Natalie S. Callander, MD

Director, Myeloma Clinical and Cellular Therapy Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts